Health for all

Our medicines, vaccines and consumer healthcare products are improving quality of life for patients and consumers around the world.

But millions of people are still not getting the vaccines and treatments they need because they can’t afford them, they can’t get them locally, or they simply don’t exist. Many countries continue to have under-resourced health systems.

To play our part in tackling these global health challenges and extend the benefits of our products to more people, we are using open innovation to target unmet medical needs, pioneering new business models to increase access to our products and collaborating to strengthen healthcare infrastructure.

Access to healthcare

We are actively seeking new ways of delivering healthcare and making our products more available and affordable to people who need them, wherever they live.

Health and well-being in communities

We aim to make a difference to communities through economic contribution, investment, education programmes and partnerships. In 2016 we invested £210 million in communities around the world.

Reinvesting in healthcare

We have committed to reinvest 20% of our profits back in to improving the healthcare infrastructure in the world’s Least Developed Countries.